newsOligonucleotide synthesis market to reach $16.7 billion by 20279 December 2022 | By Catherine Eckford (European Pharmaceutical Review)Ongoing clinical trials for oligonucleotide-based therapies will propel the oligonucleotide synthesis market to reach $16.7 billion by 2027, states a new report.